Table 1.

Patient characteristics of the full cohort of 317 patients.

		LUM (n = 200)	TN (n = 117)	LUM (100%)	TN (100%)
Age	Mean (sd)	48.7 (9.8)	44.3 (11.0)
Grade	1	10	0	5.00	0.00
	2	102	25	51.00	21.37
	3	48	70	24.00	59.83
	Missing	40	22	20.00	18.80
T-stage	1	19	10	9.50	8.55
	2	111	74	55.50	63.25
	3	50	17	25.00	14.53
	4	12	10	6.00	8.55
	Missing	8	6	4.00	5.13
N-stage	Negative	38	39	19.00	33.33
	Positive	153	72	76.50	61.54
	Missing	9	6	4.50	5.13
pCR	No	183	65	91.50	55.56
	Yes	7	46	3.50	39.32
	Missing	10	6	5.00	5.13
Treatment	6× ddAC	117	69	58.50	58.97
	6× CD	11	1	5.50	0.85
	3× ddAC, 3× CD	39	10	19.50	8.55
	Other	25	33	12.50	28.21
	Missing	8	4	4.00	3.42

LUM luminal, TN triple negative, ddAC dose-dense adriamycin + cyclophosphamide, CD capecitabine + docetaxel.